EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current and Emerging Therapies for Eosinophilic Esophagitis (EoE): A Comprehensive Review

Brooke G Musburger, Maria Gonzalez Echeandia, Elias L Suskind iD, David L Suskind iD, Hengqi Betty Zheng iD, Dominique Mark

Pharmaceutics · 07.06.2025 · 17 (6) · 753

DOI: 10.3390/pharmaceutics17060753 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 07.06.2025. Verfasst von Brooke G Musburger und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Gastroenterology, Seattle Children's Hospital, Seattle, WA 98105, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eosinophilic Esophagitis (EoE) is a chronic, immune-mediated disorder that is characterized by symptoms of esophageal dysfunction and the presence of increased eosinophils in the esophageal mucosa. It is becoming increasingly prevalent among children and adults and its pathogenesis arises from the complex interaction of genetic predisposition and environmental triggers, both which contribute to esophageal inflammation. Current societal guidelines recommend the use of proton pump inhibitors, topical steroids, and dietary interventions such as elimination diets as first-line treatments, however, the recent approval of Dupliumab has provided an additional therapeutic avenue. There are a number of investigational biologic agents targeting other immune pathways which are making their way through the pipeline of pharmacologic options in treating this chronic disorder.

Schlagwörter

Stichwörter der Autor:innen

EGIDEoEeosinophilic esophagitis

Autor:innen und Institutionen

  • Division of Pediatric Gastroenterology, Seattle Children's Hospital, Seattle, WA 98105, USA.
  • School of Life Sciences, Arizona State University, 427 E Tyler Mall, Tempe, AZ 85281, USA.
  • Department of Pharmacy, Seattle Children's Hospital, Seattle, WA 98105, USA.

ORCID-Profile: Elias L Suskind, David L Suskind, Hengqi Betty Zheng

Zitieren

APA

Musburger, B. G., Gonzalez Echeandia, M., Suskind, E. L., Suskind, D. L., Zheng, H. B., & Mark, D. (2025). Current and Emerging Therapies for Eosinophilic Esophagitis (EoE): A Comprehensive Review. Pharmaceutics, 17(6), 753. https://doi.org/10.3390/pharmaceutics17060753

Vancouver

Musburger BG, Gonzalez Echeandia M, Suskind EL, Suskind DL, Zheng HB, Mark D. Current and Emerging Therapies for Eosinophilic Esophagitis (EoE): A Comprehensive Review. Pharmaceutics. 2025;17(6):753. doi:10.3390/pharmaceutics17060753

BibTeX
@article{Musburger2025,
  author = {Musburger, Brooke G and Gonzalez Echeandia, Maria and Suskind, Elias L and Suskind, David L and Zheng, Hengqi Betty and Mark, Dominique},
  title = {Current and Emerging Therapies for Eosinophilic Esophagitis (EoE): A Comprehensive Review},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {6},
  pages = {753},
  doi = {10.3390/pharmaceutics17060753}
}
Kostenlos starten →